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1. INTRODUCTION 
Craniosynostoses, caused by the premature fusion of cranial sutures, are characterized by 
abnormal skull shape. They occur in two main forms: in the isolated (non-syndromic) type, 
craniosynostosis is not associated with other clinical signs, while in syndromic cases, facial 
dysmorphism and limb anomalies can be observed as well. 
Deformity of the skull is not only an aesthetic problem, but - depending on the type and 
etiology of the disease -, it may lead to serious neurological, ophthalmological or respiratory 
consequences requiring early surgical interventions. Therefore, early recognition and 
treatment of craniosynostosis as well as determination of the subtypes are of great clinical 
significance. Besides physical examination and applying imaging techniques (roentgen, CT), 
identification of the genetic background is also important in the diagnostics of 
craniosynostoses, in separation of isolated and syndromic forms and classification of 
patients. Genetic alterations detected have a prognostic value and allow prenatal genetic 
testing in further pregnancies; on the basis of the result, parents can decide upon the 
outcome of the pregnancy. 
Our knowledge of the clinical and genetic characteristics of patients with craniosynostosis in 
Hungary is incomplete. Identification of the syndromic forms is a diagnostic challenge 
because of their rarity and variable expressivity. A clinical center with experts experienced 
in diagnostics and treatment of craniosynostoses, formed in 2005 in Hungary, can provide a 
good opportunity for targeted and centralized medical care of these patients. From that time, 
craniofacial reconstructions have been performed in the Department of Neurosurgery, 
University of Debrecen, while the Department of Pediatrics provides the pre- and 
postoperative treatment and genetic diagnostics of patients with the contribution of 
neonatologists, pediatricians and clinical geneticists. This situation provides a great 
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opportunity to overview and summarize our experience in the clinical and genetic 
characteristics of craniosynostosis and genotype-phenotype correlations. 
 
2. LITERATURE REVIEW 
Craniosynostoses, the premature fusion of cranial sutures, are characterized by the deformity 
of the skull. It is one of the most frequent form of craniofacial disorders with an incidence of 
1:2100-2500 births. Early fusion of the sutures usually begins prenatally, thus 
craniosynostosis can be diagnosed mostly in newborns. In the isolated (non-syndromic) 
forms (80-85% of patients), besides the cranial deformity and its potential consequences (e. 
g., increased intracranial pressure, brain blood flow, respiratory distress, visual and hearing 
impairment), no other specific clinical signs could be observed. In the contrary, in 
syndromic forms the cranial abnormality often associates with further specific symptoms 
including various facial dysmorhic signs and limb anomalies, however, there is an 
overlapping between the phenotypes. More than 100 syndromes associated with 
craniosynostosis are known nowadays.  
2.1 Etiology of craniosynostosis 
The isolated forms are mostly sporadic, their etiology is not entirely clarified yet. They are 
considered to be of multifactorial origin: both the genetic background and environmental 
factors may play an important role in their development. By epidemiological studies, the 
main risk factors of isolated craniosynostoses are - among others- the male sex, high 
(>4000g) or low (<1500g) birth weight, preterm (<37 week) birth, breech presentation, 
plurality and advanced (>35 years) maternal age. Smoking, medication (e. g. antiepileptic 
drugs) or alcohol use during pregnancy may also predispose to craniosynostosis. In contrast 
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with the isolated group, syndromic forms are mostly caused by genetic alterations, which 
can be gene mutations or chromosomal aberrations.  
2.1.1. Gene alterations 
In about 25% of craniosynostoses, pathogenic mutations can be detected in genes playing 
important role in the differentiation and proliferation of osteoblasts and ossification. The 
most frequently involved genes in craniosynostosis are those encoding the fibroblast growth 
factor receptors and the TWIST1 (twist family basic helix-loop-helix transcription factor 1) 
transcription factor. 
Fibroblast growth factor receptors (FGFR) and their genes 
The four members of FGF receptor family (FGFR1-4) are transmembrane signal 
transduction molecules with tyrosine kinase activity. They consist of an extracellular ligand 
binding part with 3 immunoglobulin-like domains (IgI, IgII, IgIII), a transmembrane domain 
and a splitted intracellular tyrosine kinase domain. The IgIII domain is located in the center 
of the ligand binding part of the receptor, thus its amino acid sequence is crucial for the 
specificity of ligand binding. The ligands of the receptors are the FGF molecules consisting 
of 23 members, the ligand specificity of the receptors is different. They play an important 
role in organogenesis, neurogenesis, wound heeling and endochondral or intramembranous 
ossification. 
In the development of craniosynostosis, FGFR1-3 genes are involved. Heterozygous, 
activating mutations of FGFR2 can be identified in several syndromes such as Apert, 
Crouzon or Pfeiffer syndromes. Most of these mutations are missense and located in the two 
hotspot regions (exon IIIa and IIIc) of the gene. The p.Pro252Arg mutation in FGFR1 is 
specific for Pfeiffer syndrome type 1, while in the FGFR3 gene, 2 mutations are known to 
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cause syndromic craniosynostosis (p.Pro250Arg, Muenke syndrome; p.Ala391Glu, Crouzon 
syndrome with acanthosis nigricans). FGFR mutations cause gain of function, the receptors 
become activated constantly. Enhanced signal transduction results in increased proliferation 
and differentiation inducing intense ossification.  
TWIST1 transcription factor and its gene 
The TWIST1 molecule, a member of the basic helix-loop-helix transcription factor family, 
has a crucial role in the development of the skeleton as a key molecule of mesenchymal cell 
death. It has a positive or negative effect on the proliferation, differentiation and survival of 
osteoblasts through the regulation of several signal transduction pathways. It regulates the 
development of the cranial sutures indirectly through the BMP (bone morphogenetic 
protein) and FGF pathways. Heterozygous, loss-of-function mutations in the coding exon of 
TWIST1 are various: they can be missense, nonsense or frameshift mutations. In certain 
cases, deletion of the whole gene or larger region can be found leading to microdeletion. 
TWIST1 mutations cause craniosynostosis by haploinsufficiency. 
The common craniosynostosis syndromes show autosomal dominant inheritance. In 
syndromes with serious phenotype (e. g., Apert or Pfeiffer syndrome type 2), new mutations 
are expected, while in milder syndromes (e.g., Muenke or Crouzon syndromes) familial 
cases can also be observed. 
 
2.1.2 Chromosomal abnormalities 
Several chromosomal aberrations have been described in craniosynostosis, most of them are 
sporadic. One part of the cytogenetic aberrations involves the 7p21.1 region containing the 
TWIST1 gene, which translocation or deletion cause Saethre-Chotzen syndrome. Other 
7 
aberrations include terminal 9p, 11q23 or 22q11 deletions, 1p36 or 5q35 trisomies, etc. In 
certain cases without chromosomal aberrations, various submicroscopic alterations may be 
detected with multiplex ligation dependant probe amplification or array comparative 
genome hybridization (arrayCGH). Chromosomal aberrations constitute about 15% of 
genetically proved cases. 
 
3. AIMS OF THE STUDY 
1. The aim of our study was to investigate the clinical and genetic aspects of patients 
with syndromic craniosynostosis referred to the Department of Pediatrics and 
Department of Neurosurgery, and establish genotype-phenotype correlations. 
2. We intended to use cytogenetic, molecular cytogenetic and molecular genetic 
methods to detect genetic aberrations. 
3. In the case of a new mutation, additional analyses were planned to use to confirm 
its pathogenecity.  
4. In the knowledge of the genetic aberration and the clinical signs, we studied 
whether there is a correlation between the genotype and the phenotype, the 
severity and the outcome of the surgical intervention. 
5. In familial cases, examination of the proband was complemented with the 
investigation of family members to enhance the better recognition of the rarer 
syndromes. 
6. On the basis of our results, we aimed to establish a genetic algorithm, which can 
be effectively used in diagnostics. 
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7. Besides the investigation of the syndromic forms, we studied the frequency of 
different types of isolated craniosynostosis, and the role of selected perinatal 
factors in the development of the disorder.  
 
4. PATIENTS AND METHODS 
4.1.Patients 
Two hundred patients with craniosynostosis were referred to the Department of 
Neurosurgery and Department of Pediatrics, University of Debrecen between the years 2006 
and 2012. Synostosis of the sutures was confirmed by either X-ray or computed 
tomography, and the syndromic nature of the disease was established by a team of 
pediatricians and clinical geneticists. Of the 200 enrolled patients, 198 were under 10 years 
of age with a median age of 6 months (1 month-10 years), while only 2 patients were adults 
(18 and 28 years old). Reconstructive operative procedures were performed in 195 patients. 
In 24 patients, clinical signs other than the malformed skull suggested the syndromic forms 
of the disease. Patients diagnosed with craniosynostosis syndromes during the seven years 
of the study had the following types: Apert (n=5), Pfeiffer (n=5), Muenke (n=4), Crouzon 
(n=2) and Saethre-Chotzen (n=1) syndromes. Multiple-suture craniosynostosis associated 
with achondroplasia was found in one patient (n=1). Phenotypic features were not typical 
for any particular syndrome in six patients.  
 
4.2. Methods 
To investigate the etiology of the disease genetic analyses were performed only in patients 
with clinically identified or suspected syndromic craniosynostosis and their relatives 
showing the clinical signs of a specific syndrome. Genetic testing included the molecular 
9 
analysis of the mutational hotspots of the FGFR1, FGFR2, FGFR3 and TWIST1 genes, G-
banded karyotyping and fluorescence in situ hybridization (FISH) analysis of TWIST1. If a 
specific syndrome was identified (n=18), targeted analysis was performed, while in 
suspected syndromic cases (n=6) all of the previously mentioned tests were applied. In one 
patient arrayCGH analysis was also performed. After obtaining written informed consent, 
blood samples were taken from 24 syndromic patients and 8 relatives. To assess the 
pathogenecity of the novel mutation, DNA samples of 50 healthy, controll persons were 
analyzed. 
4.2.1. DNA extraction 
To examine the mutational hotspots, genomic DNA was extracted from the patients’ 
peripheral blood using the QIAamp DNA Blood Mini kit (Qiagen, Germantown, MD) 
according to the manufacturer’s instruction.  
4.2.2. Mutational analysis of the FGFR1, 2, 3 and TWIST1 genes 
Amplification of exon 7 of FGFR1, exons 8 and 10 of FGFR2, exons 7 and 10 of FGFR3, 
and the coding region of exon 1 in TWIST1 was performed by polymerase chain reaction 
(PCR) with previously published primer pairs. For DNA sequencing, the PCR products were 
purified using the MinElute PCR Purification Kit (Qiagen, Germantown, MD, USA). 
Purified PCR products were sequenced on the ABI 3100 sequencer (Applied Biosystems, 
Foster City, CA, USA) with the Big Dye Terminator v3.1 cycle sequencing kit (Applied 
Biosystems, Foster City, CA, USA). Electropherograms of the sequenced products were 
compared to reference sequences. 
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4.2.3. Assessing the pathogenicity of the novel variant 
To assess the pathogenicity of the novel variant, c.528C>G (p.Ser176Arg) in exon 1 of 
TWIST1, SIFT (http://sift.jcvi.org) and Polyphen-2 (http://genetics.bwh.harvard.edu/pph2/) 
predictions were performed. Alignment analysis of TWIST1 proteins was carried out using 
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). The presence of the novel 
variant was tested by restriction fragment length polymorphism (RFLP) analysis using 
BspMI (Thermo Scientific, Waltham, MA, USA) restriction enzyme in 50 healthy 
individuals. 
4.2.4. Cytogenetic analysis 
To detect the constitutional karyotype of the patients, conventional karyotyping was 
performed. Blood samples (0.5 mL) of patients anticoagulated with Na-heparin were 
cultured in medium (5 mL, Lymphochrome Medium, Lonza, Belgium) during 72 hours, at 
37 degrees in a CO2 (5%) incubator. To interrupt cell division, colchicin (0.5 ug/ml, Sigma-
Aldrich, St. Louis, MO, USA) was added to the samples, and after incubation (1 hour), 
hypotonization of the samples were performed with 0,075 M KCl solution. Fixation of the 
samples was performed with methanol-acetic acid (3:1) solution. For chromosome banding, 
treatment with trypsin (Sigma-Aldrich, St. Louis, MO, USA) was used followed by Giemsa 
staining (Merck, Darmstadt, Germany). We evaluated 10 metaphases with Lucia Karyo 
software (Lucia Cytogenetics, Czech Republik) in every patient. Determination of the 
karyotype was based on the International System for Human Cytogenetic Nomenclature 
(ISCN 2005 and 2009).  
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4.2.5. FISH analysis of TWIST1  
FISH analysis was performed using cell suspension derived from chromosome preparation. 
After dropping and aging (37 oC, one hour), slides were pretreated with the following 
solutions: 2xSSC/0.5% NP40, 37 oC, 15 minutes; pepsin treatment, 37 oC, 5 minutes; 1x 
PBS, room temperature, 5 minutes. After dehydration (70%-85%-100% ethanol, 2-2 
minutes) and drying, 1.5 µl probe (Williams-Beuren/Saethre-Chotzen probe, Cytocell, 
Cambridge, UK) was dropped onto the slide, and it was covered by a coverslip. 
Codenaturation of the sample and the probe was performed at 76 oC for 3 minutes, and 
hybridization was performed at 37 oC, overnight in a hybridization machine (Hybrite, 
Abbott/Vysis, Des Plaines, IL, USA). We washed the unbounded probe in 50% 
formamid/2X SSC solution at 42 °C, for 15 minutes, in 2X SSC solution at room 
temperature for 10 minutes and in 2X SSC/ 0,1 % NP40 solution at room temperature for 5 
minutes. After drying, cell nuclei were stained with 4’-6’ diamino-2-fenil-indol (DAPI, 
Abbott/Vysis, Des Plaines, IL, USA). Evaluation of the samples was performed with Zeiss 
Axioplan2 microscope (Carl Zeiss, Jena, Germany) and ISIS software (Metasystems, 
Altlussheim, Germany). At least 15 metaphases were evaluated in every patient. 
 
4.2.6. ArrayCGH analysis 
 ArrayCGH analysis was performed in a patient with multiple-suture craniosynostosis and 
achondroplasia at the Department of Clinical Genetics, Academic Medical Centrum, 
Amsterdam, Netherlands with  Agilent 180K oligo-array, Amadid 023363 (Agilent 
Technologies, Inc., Santa Clara, CA, USA). Standard methods were used for labelling and 
hybridization, array profiles were evaluated by Agilent software. 
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4.2.7. Statistical analysis 
To assess the potential risk factors for craniosynostosis, selected perinatal data (sex, 
plurality, gestational age at birth and birth weight) of 142 non-syndromic patients were 
compared with the general Hungarian live births data (average data of 2005-2010 years) 
provided by the Hungarian Central Statistical Office. Statistical analyses included Chi-
square and Fisher’s exact tests performed by IBM SPSS 20 (IBM Corporation, Armonk, 
New York). The results were considered to be significant at a < 0.05 significance level.   
 
5. RESULTS 
Two hundred patients with craniosynostosis were enrolled in the study. On the basis of 
detailed clinical assessment, the condition proved to be isolated (nonsyndromic) in 176 of 
200 (88%) patients while 24 cases (12%) were syndromic.  
5.1. Clinical symptoms of syndromic patients 
Clinical signs in patients with Apert syndrome included brachycephaly due to bicoronal 
synostosis, high and broad forehead, midface hypoplasia, depressed nasal bridge, convex 
nasal ridge, hypertelorism and syndactyly of fingers and toes. In the majority of patients, 
syndactyly of all toes on both feet and syndactyly of the 2/3/4/5 fingers on both hands were 
observed (Patients 1-4). In Patient 5, complete syndactyly of all fingers and all toes could be 
seen. Cleft palate was observed in one patient. 
Both patients with Crouzon syndrome showed brachycephaly, proptosis, flat nasal bridges, 
mandibular prognathism and low-set ears. In one of them acanthosis nigricans was also 
present.  
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Three of the patients with Pfeiffer syndrome had severe cranial malformation (cloverleaf or 
“Kleeblattschädel” skull), hydrocephalus, extreme proptosis, low-set ears and short, small 
noses. Broad great toes were observed in all of these patients, while the thumbs were broad 
only in two of them. Limited extension of the elbows was also noticed in two patients. In a 
patient, medially deviated great toes, the characteristic feature of Pfeiffer syndrome, were 
observed and were associated with partial 2/3 syndactyly on the feet. Based on the 
phenotypic signs, the latter three patients were considered to have Pfeiffer syndrome type 2. 
In two further patients, Pfeiffer syndrome type 1 was diagnosed based on craniofacial 
anomalies milder than those in patients with type 2. One of them had brachycephaly, a high 
and broad forehead, exophthalmos, broad thumbs, 3/4 syndactyly of the fingers, broad great 
toes and 2/3/4 syndactyly on the toes. The other patient had brachy- and acrocephaly, high 
forehead, wide and depressed nasal bridge, hypertelorism, long philtrum, thin lips, low set 
ears with overfolded helices. Limb anomalies included broad thumbs, broad great toes with 
varus deformity, complete 3/4 cutaneous syndactyly of the right foot and 2/3/4 partial 
cutaneous syndactyly of the left. Detailed clinical and genetic investigations of the other 
patient and her 4 family members were performed.  
All of the Muenke syndrome patients had brachycephaly resulting from the synostosis of the 
coronal sutures, high and flat foreheads, hypertelorism and almond-shaped eyes. High-
arched palate was seen in two of them. Limb abnormalities were variable, including broad 
thumbs and great toes, clinodactyly of the fifth fingers and capitate-hamate fusion. The 
mothers of three patients showed similar phenotypes to those of their children, but their 
clinical signs seemed to be milder.  
Typical clinical signs of Saethre-Chotzen syndrome were observed in a patient, who had 
brachycephaly, an asymmetric flat face, long and deviated nose, thin lips, ptosis of the right 
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eyelid, shallow orbits, and broad and bifid great toes. The mother of the patient also had 
brachycephaly, a long nose, thin lips and bifid great toes; additionally, her thumbs were 
broad.  
Multiple-suture craniosynostosis associated with rhizomelic shortening of the limbs and 
trident hands, the typical clinical signs of achondroplasia were found in a patient.  
 In six patients, additional clinical features associated with craniosynostosis included various 
facial dysmorphic signs and limb alterations suggesting the syndromic form of 
craniosynostosis; however, the phenotypes of these patients were not typical for any 
particular syndrome. 
5.2. Genetic alterations in syndromic patients 
The Apert and Pfeiffer syndromes could most commonly be observed in the syndromic 
group. Genetic abnormalities were detected in 75% (18/24) of the syndromic patients and in 
8 relatives showing the clinical signs of a specific syndrome. All mutations were 
heterozygouos.  
In 4 patients with Apert syndrome, we identified the c.758C>G (p.Pro253Arg) mutation in 
FGFR2, while in one patient the c.755C>G (p.Ser252Trp) mutation of the same gene could 
be detected. Both mutations are specific for this syndrome.   
In 4 patients with Pfeiffer syndrome, the FGFR2 gene was involved: in three cases various 
changes of the 342. amino acid were detected (c.1024T>C, p.Cys342Arg és c.1025G>C, 
p.Cys342Ser), while in one patient a splicing mutation (c.940-1G>A) could be identified. 
The rare c.755C>G p.Pro252Arg mutation of FGFR1 was detected in the patient with 
Pfeiffer syndrome type 1 characterized by mild symptoms. Detailed clinical genetic 
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examination of the family was performed, and the mutation was proved in further 4 family 
members. 
In one of the patients with Crouzon syndrome the c.833G>T (p.Cys278Phe) mutation of 
FGFR2 was detected, in the other patient with acanthosis nigricans, the c.1172C>A 
(p.Ala391Glu) mutation in the FGFR3 gene was found. 
The mutation specific for Muenke syndrome, the c.749C>G (p.Pro250Arg) in FGFR3, could 
be detected in 4 patients, three of them inherited it from their mothers. 
In the patient with achondroplasia and multiple-suture craniosynostosis, the achondroplasia-
specific c.1138G>A (p.Gly380Arg) mutation was found. Any other genetic alteration which 
may have been related to the associating craniosynostosis, could not be identified by 
sequencing of the hotspot regions of FGFR1-3, G-bandig karyotyping, FISH and arrayCGH.  
In addition to 10 different, known mutations detected in FGFR1-3, one previously 
undescribed missense mutation, the c.528C>G (p.Ser176Arg), was found in the TWIST1 
gene of a patient with Saethre-Chotzen syndrome. 
 
5.3. Assessing the pathogenecity of the new mutation p. Ser176Arg 
The pathogenicity of the new mutation, c.528C>G (p.Ser176Arg), is supported by the 
following arguments:  
1. the affected residue is phylogenetically highly conserved in human, mouse, 
zebrafish and xenopus;  
2. according to SIFT and PolyPhen-2 predictions, this missense alteration was 
predicted to be damaging and probably damaging, respectively;  
3. RFLP analysis of exon 1 of TWIST1 showed that this mutation was not present in 
50 healthy individuals representing 100 alleles. 
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4. The mother, who had very similar phenotype also had the novel c.528C>G 
(p.Ser176Arg) mutation. 
5.4. The role of selected perinatal risk factors in non-syndromic craniosynostoses 
In the isolated group, the most frequently fused suture was the sagittal one (120/176; 68%) 
followed by the coronal (26/176; 15%), metopic (18/176; 10%) and lambdoid sutures 
(7/176; 4%) in this order. In 5 patients (3%), more than one suture was involved. The male-
to-female ratio was 2.2:1, showing a male predominance. 
Perinatal data of 142 nonsyndromic patients were compared to the general Hungarian live 
birth data to assess their possible associations with craniosynostosis. Male sex (P< 0.001), 
twin gestation (P< 0.001) and very low (< 1500 g) birth weight (P< 0.001) proved to be risk 
factors for nonsyndromic craniosynostosis. Being male (P< 0.001) and twin gestation 
(P=0.001) seemed to  be associated with sagittal synostosis, while very low birth weight was 
a predictor for coronal (P<0.001) synostosis. No association between metopic synostosis 
and any risk factor analyzed in the study could be confirmed. Because of the small number 
of patients, no statistical analysis could be performed on lambdoid synostosis. 
 
6. DISCUSSION 
Our study is the first nation-wide investigation providing clinical and genetic information on 
craniosynostoses. Similarly to previously published studies, nonsyndromic patients 
represented the majority of all cases, while syndromic forms constituted only the 12% of 
craniosynostoses. 
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6.1. Genetic alterations in syndromic craniosynostoses   
Genetic abnormalities were detected in syndromic patients with clinical signs characteristic 
for a specific syndrome. 
6.1.1. Genotype-phenotype correlations  
Apert syndrome is one of the most serious craniosynostosis syndromes with specific clinical 
signs. According to the literature, the specific mutations p.Ser252Trp and p.Pro253Arg of 
FGFR2 can be detected in about 99% of patients with Apert syndrome, while Alu-element 
insertions in FGFR2 are a rare cause of this condition. In our study, all patients with Apert 
syndrome carried one of the two specific mutations. While the p.Ser252Trp mutation could 
be detected in only one patient in our study, other authors found this mutation with a higher 
frequency. Regarding the clinical features, cleft palate has been reported to be more 
common with the p.Ser252Trp mutation, while syndactyly was found to be more severe in 
patients with the p.Pro253Arg mutation. Our result supports this observation: the only 
patient, who had cleft palate, carried the p.Ser252Trp mutation. 
Pfeiffer syndrome is known to be clinically and genetically heterogenous disorder. The two 
ends of the phenotypical spectrum are represented by the very mild, almost unrecognizable 
cranial deformity on one hand and the severe cloverleaf skull on the other. The mutations 
eliminating the cysteine 342 residue in FGFR2 have a different phenotypic impact 
depending on the type of amino acid exchange. The conversion of cysteine to phenylalanine 
or tyrosine mainly results in Crouzon syndrome, whereas arginine substitution preferentially 
causes Pfeiffer syndrome with severe cranial manifestation and poor prognosis. In our 
cohort, two patients with Pfeiffer syndrome harbored the p.Cys342Arg mutation; both of 
them had cloverleaf skulls requiring two and three reconstructive surgical interventions, 
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hydrocephalus, severe exophthalmos, and respiratory and auditory problems. In addition, 
exchange of the same amino acid residue for serine caused very similar, severe phenotype in 
the third patient with Pfeiffer syndrome type 2. The mild form of Pfeiffer syndrome, the 
type 1 was observed in two patients. In one of them, splicing mutation of FGFR2 (c.940-
1G>A) was identified, while the other patient had the p.Pro252Arg mutation in FGFR1. 
In 1994 Muenke et al. identified the FGFR1 gene on chromosomal region 8p11 to be 
associated with Pfeiffer syndrome. A specific mutation, p.Pro252Arg, located in the IgII-III 
linker region of FGFR1, has been reported to cause mild symptoms making the diagnosis 
rather difficult in many cases. FGFR1 p.Pro252Arg mutation without craniosynostosis has 
been reported on two occasions in the literature providing a further evidence of variable 
expressivity of the syndome. Phenotypic features in the family with the mutation above 
showed high variability ranging from apparently normal skull and limbs to characteristic 
brachycephaly and digital anomalies. Typical features of the syndrome appeared only in the 
third generation, suggesting that this condition is underdiagnosed in many cases. In the case 
of FGFR1 p.Pro252Arg mutation, a variable expressivity can b e expected which in mild 
cases makes the diagnosis difficult. The case of this family emphasizes the significance of 
detailed physical examination of not only the proband but the family members as well, 
because the specific symptoms of the syndrome may occasionally appear only after several 
generations.  
Crouzon syndrome is usually caused by FGFR2 mutations. Association of the syndrome 
with acanthosis nigricans is very rare and considered to be a separate entity called 
Crouzonodermoskeletal syndrome because of its specific phenotype and genotype. The 
specific alteration of the syndrome is the c.1172C>A (p.Ala391Glu) mutation of FGFR3. In 
contrast to the common FGFR1 and 2 mutations located in the extracellular part of the 
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receptor, this mutation is found in the transmembrane region of FGFR3 enhancing 
signalization by the stabilization of receptor dimers. In one patient with Crouzon syndrome, 
a common mutation of the syndrome, c.833G>T, p.Cys278Phe in FGFR2, was found, while 
in the other patient acanthosis nigricans was also present and the former specific mutation 
was detected. Because of the former observations, besides cranial deformity and facial 
dysmorphism we must pay special attention to the skin, but limb anomalies are not expected. 
Muenke syndrome is characterized by the synostosis of the coronal suture, very mild facial 
dysmorphism, limb anomalies which can be seen sometimes only by X-ray imaging and the 
presence of the specific FGFR3 p.Pro250Arg mutation. The syndrome was identified in 4 
patients, three probands inherited the mutation from their mothers. Recent international 
studies recommend the mutational analysis in every patient with isolated craniosynostosis 
involving the coronal suture in order to detect the very mild, almost unrecognizable 
assocating synostosis and facial dysmorphy. In a patient with Saethre-Chotzen syndrome we 
succeeded to identify a novel missense mutation, p.Ser176Arg, in TWIST1. TWIST1 is a 
basic helix-loop-helix transcription factor involved in a variety of signal transduction 
pathways in tissues of mesodermal origin. It has a crucial role in the migration and 
differentiation of cranial neural crest cells during cranial development. The novel alteration 
is located between the highly conserved bHLH and Twist box domains. Although this linker 
region is evolutionarily conserved across a wide range of vertebrate species, its functional 
importance is still unclear. Pathogenecity of the variant is supported by the conservity of the 
176. amino acid of the human TWIST1, the probable damaging effect of serine-arginine 
exchange, the lack of the mutation in the healthy control population examined, and its 
presence in the mother showing the clinical signs of the syndrome.  
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6.1.2. Association of craniosynostosis with achondroplasia  
Association of achondroplasia, as the most common form of chondrodysplasias, with 
craniosynostosis is extremely rare, only 3 cases have been reported before our publication. 
In our patient, acrocephaly and left posterior plagiocephaly was observed due to multiple-
suture craniosynostosis. The achondroplasia-specific mutation could be detected, but a 
second pathogenic mutation which may have lead to the simultaneously existing 
craniosynostosis could not be identified in the hot-spot regions of FGFR1, 2, 3 and TWIST1. 
Cytogenetic and array CGH analysis also gave normal result. Our case and the reported ones 
suggest that this combined phenotype may be related to a variable expressivity of the 
common mutation of achondroplasia. It can be suspected, that modifier gene(s) may exist in 
the genome altering the phenotypic outcome of the achondroplasia-specific mutation. In 
addition, epigenetic or environmental influences may also modify the manifestation of the 
disease.  
 
6.2  Characteristics of isolated craniosynostoses – predisposing factors   
Similarly to previously published studies, nonsyndromic patients represented the majority of 
all cases with craniosynostosis, and the most frequently involved suture was found to be the 
sagittal one, followed by the coronal, metopic and lambdoid sutures. The frequency of 
sagittal synostosis was 68%, higher than in other populations. Assessing the relationship 
between potential risk factors and craniosynostosis, it was found - in accordance with 
previous studies - that sagittal synostosis was frequently associated with male sex and twin 
gestation. Several studies confirmed the role of maternal smoking as a risk factor for 
craniosynostosis, especially the sagittal type. According to data from the World Health 
Organization (2011), the estimated prevalence of daily smoking in Hungarian females is 
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26%, which is much higher than in many other countries (United Kingdom, 14%; United 
States, 13%; Australia, 15%). Although smoking behavior of mothers was not studied in our 
patient cohort, we can speculate that smoking can be one of the potential causes of the 
higher involvement of the sagittal suture in Hungarian patients with craniosynostosis. 
6.3. Diagnostic aspects and genetic algorithm 
Detailed clinical genetic examination has an important role in not only the recognition the 
different forms of the disease, but also has a prognostic significance and allows early 
surgical intervention. 
On the basis of our experience and data in the international studies, we established a 
molecular diagnostic algorithm for the genetic examination of craniosynostosis in the 
country. If the clinical signs are specific for a certain syndrome, targeted analyses should be 
performed in a given order to maximize the diagnostic effectivity. If the symptoms propose 
the syndromic form of craniosynostosis, but they are not specific for a certain syndrome, 
conventional cytogenetic analysis is recommended at first, followed by the mutational 
analysis of hotspot regions of the responsible genes.  
As the etiology of the isolated group is very heterogeneous and probably is of multifactorial 
origin, genetic tests are proposed only in certain cases (e.g., involvement of the coronal 
suture, multiple-suture synostosis, familial cases). From a clinical point of view, it is 
important, that the knowledge of the genetic background may call our attention to the 
expected associating clinical signs and anticipate the probable required number of surgical 
interventions. In genetically determined forms, the probability of refusion, pansynostosis 
and progression is greater. Reconstruction of the cloverleaf skull in our patients with Apert 
syndrome recquired 2 or 3 surgical intervetions, while the correction of syndactyly also 
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needed several operations. Besides the treatment of craniofacial alterations, increased 
intracranial pressure (hydrocephalus), extreme proptosis and respiratory problems also 
required surgical interventions in the Pfeiffer syndrome of severe type 2 and 3. 
Crouzon, Muenke and Pfeiffer syndrome type 1 are usually characterized by mild cranial 
deformity. As a result of this, three patients with Muenke syndrome in our cohort did not 
need any reconstruction. 
Additional significance of the genetic diagnosis is the possibility of targeted prenatal testing 
in familial cases. On the basis of the result, couples can decide the outcome of the 
pregnancy. As a result of our contribution, three healthy babies have been born so far. 
 
New results of the dissertation 
1. We performed comprehensive clinical and genetic investigation of patients with 
craniosynostosis at first in the country. Taking the advantage of the leader role of 
the Department of Neurosurgery in craniofacial surgery, we performed a national 
center for the clinical and genetic examination of patients with craniosynostosis.  
2. We achieved expansive genetic examination of syndromic craniosynostoses and 
established a diagnostic algorithm for effective and economical testing. 
3. In 75% of syndromic cases, genetic alterations could be detected. 
4. We identified a novel mutation (p.Ser176Arg) in the TWIST1 gene of a patient 
with Saethre-Chotzen syndrome, and supported its pathogenecity with additional 
tests. 
5. By the investigation of genotype-phenotype correlations, several observation were 
made:  
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- We confirmed the correlation between the type of the mutation and the 
phenotype in Apert, Crouzon and Pfeiffer syndromes.  
- We performed genotype–phenotype analyses in the family of a patient with 
Pfeiffer syndrome type 1 and p.Pro252Arg mutation and confirmed, that this 
mutation is associated with variable expressivity.  
- We noticed, that specific signs of the syndrome appear only after several 
generations, which call attention to detailed family studies.  
6. We confirmed the previous observation, that the rare association of 
achondroplasia and multiple-suture craniosynostosis is the consequence of the 
p.Gly380Arg mutation of FGFR3, which supports the role of this mutation both in 
endochondral and intramembranous ossification. 
7. On the basis of statistical analyses, we stated that male sex, twin gestation and 
very low birth weight are risk factors for non-syndromic craniosynostosis. 
8. We observed, that the involvement of sagittal synostosis in isolated patients is 
significantly higher in the Hungarian population than in other countries, which 
underlines the significance of further investigation of risk factors.  
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7. SUMMARY 
Craniosynostosis, the premature fusion of cranial sutures, is a clinically and etiologically 
heterogeneous group of disorders. Both environmental and genetic factors play an important 
role in the development of isolated (non-syndromic) forms found in the majority of patients, 
while syndromic cases are frequently caused by gene mutations or more rarely chromosomal 
aberrations. The aim of our work was to study the clinical and genetic characteristics of 
patients with craniosynostosis syndromes and to assess the genotype-phenotype correlations. 
In isolated craniosynostoses, the pathogenetic role of infant sex, birth weight, gestational 
age and plurality was retrospectively studied.  
Using various methods, pathogenic mutations were identified in 75% of syndromic patients. 
In five cases, the mutations proved to be familial. In the FGFR1, 2, 3 and TWIST1 genes, 11 
different mutations were detected. No chromosomal aberrations could be identified. In a 
patient with Saethre-Chotzen syndrome, a novel pathogenic mutation, p.Ser176Arg, in the 
TWIST1 gene was found. In a family with Pfeiffer syndrome due to FGFR1 p.Pro252Arg 
mutation, we observed a variable expressivity with specific signs of the syndrome appearing 
only in successive generations. In a patient with simultaneous achondroplasia and multiple-
suture craniosynostosis, the achondroplasia-specific mutation, p.Gly380Arg, was confirmed 
without any further genetic abnormality suggesting that this mutation has an influence on 
both endochondral and intramembranous bone formation. Based on our experiments, we 
developed an algorithm for genetic diagnosis of syndromic craniosynostosis. A relationship 
between selected perinatal risk factors (male sex, twin gestation and low birth weight) and 
isolated craniosynostosis was found. Clarification of the genetic background of 
craniosynostosis and establishment of genotype-phenotype correlations are of important 
diagnostic and prognostic significance offering the possibility for targeted prenatal testing. 
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